Novasenta develops treatments to transform the lives of patients with cancer.
Novasenta has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.
Novasenta's investors include UPMC Enterprises.
Novasenta is headquartered in Pittsburgh, United States.
Novasenta develops treatments to transform the lives of patients with cancer.
Novasenta is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novasenta — Funding & Investors." VCBacked, February 5, 2024, https://www.vcbacked.co/company/novasenta. Accessed September 30, 2026.
VCBacked. (2024). Novasenta — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/novasenta
{{cite web |title=Novasenta — Funding & Investors |url=https://www.vcbacked.co/company/novasenta |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated